282 related articles for article (PubMed ID: 28289281)
1. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.
Lee MR; Scheidweiler KB; Diao XX; Akhlaghi F; Cummins A; Huestis MA; Leggio L; Averbeck BB
Mol Psychiatry; 2018 Jan; 23(1):115-122. PubMed ID: 28289281
[TBL] [Abstract][Full Text] [Related]
2. Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.
Modi ME; Connor-Stroud F; Landgraf R; Young LJ; Parr LA
Psychoneuroendocrinology; 2014 Jul; 45():49-57. PubMed ID: 24845176
[TBL] [Abstract][Full Text] [Related]
3. Plasma and CSF oxytocin levels after intranasal and intravenous oxytocin in awake macaques.
Freeman SM; Samineni S; Allen PC; Stockinger D; Bales KL; Hwa GG; Roberts JA
Psychoneuroendocrinology; 2016 Apr; 66():185-94. PubMed ID: 26826355
[TBL] [Abstract][Full Text] [Related]
4. CSF and blood oxytocin concentration changes following intranasal delivery in macaque.
Dal Monte O; Noble PL; Turchi J; Cummins A; Averbeck BB
PLoS One; 2014; 9(8):e103677. PubMed ID: 25133536
[TBL] [Abstract][Full Text] [Related]
5. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques.
Lee MR; Shnitko TA; Blue SW; Kaucher AV; Winchell AJ; Erikson DW; Grant KA; Leggio L
Nat Commun; 2020 Jun; 11(1):2783. PubMed ID: 32494001
[TBL] [Abstract][Full Text] [Related]
6. Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates.
Bauman MD; Murai T; Hogrefe CE; Platt ML
Am J Primatol; 2018 Oct; 80(10):e22913. PubMed ID: 30281820
[TBL] [Abstract][Full Text] [Related]
7. Measuring peripheral oxytocin and vasopressin in nonhuman primates.
Ziegler TE
Am J Primatol; 2018 Oct; 80(10):e22871. PubMed ID: 29756649
[TBL] [Abstract][Full Text] [Related]
8. Effects of positive and negative human contacts and intranasal oxytocin on cerebrospinal fluid oxytocin.
Rault JL
Psychoneuroendocrinology; 2016 Jul; 69():60-6. PubMed ID: 27032064
[TBL] [Abstract][Full Text] [Related]
9. Effects of route of administration on oxytocin-induced changes in regional cerebral blood flow in humans.
Martins DA; Mazibuko N; Zelaya F; Vasilakopoulou S; Loveridge J; Oates A; Maltezos S; Mehta M; Wastling S; Howard M; McAlonan G; Murphy D; Williams SCR; Fotopoulou A; Schuschnig U; Paloyelis Y
Nat Commun; 2020 Mar; 11(1):1160. PubMed ID: 32127545
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS measurement of endogenous oxytocin in the posterior pituitary and CSF of macaques: A pilot study.
Erikson DW; Blue SW; Kaucher AV; Shnitko TA
Peptides; 2021 Jun; 140():170544. PubMed ID: 33811949
[TBL] [Abstract][Full Text] [Related]
11. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
[TBL] [Abstract][Full Text] [Related]
12. Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans.
Striepens N; Kendrick KM; Hanking V; Landgraf R; Wüllner U; Maier W; Hurlemann R
Sci Rep; 2013 Dec; 3():3440. PubMed ID: 24310737
[TBL] [Abstract][Full Text] [Related]
13. Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates.
Boccia ML; Goursaud AP; Bachevalier J; Anderson KD; Pedersen CA
Horm Behav; 2007 Sep; 52(3):344-51. PubMed ID: 17583705
[TBL] [Abstract][Full Text] [Related]
14. Intranasal oxytocin selectively modulates the behavior of rhesus monkeys in an expression matching task.
Taubert J; Flessert M; Liu N; Ungerleider LG
Sci Rep; 2019 Oct; 9(1):15187. PubMed ID: 31645593
[TBL] [Abstract][Full Text] [Related]
15. Peripheral Administration of a Long-Acting Peptide Oxytocin Receptor Agonist Inhibits Fear-Induced Freezing.
Modi ME; Majchrzak MJ; Fonseca KR; Doran A; Osgood S; Vanase-Frawley M; Feyfant E; McInnes H; Darvari R; Buhl DL; Kablaoui NM
J Pharmacol Exp Ther; 2016 Aug; 358(2):164-72. PubMed ID: 27217590
[TBL] [Abstract][Full Text] [Related]
16. Intranasal oxytocin effects on social cognition: a critique.
Evans SL; Dal Monte O; Noble P; Averbeck BB
Brain Res; 2014 Sep; 1580():69-77. PubMed ID: 24239931
[TBL] [Abstract][Full Text] [Related]
17. Intranasal oxytocin selectively attenuates rhesus monkeys' attention to negative facial expressions.
Parr LA; Modi M; Siebert E; Young LJ
Psychoneuroendocrinology; 2013 Sep; 38(9):1748-56. PubMed ID: 23490074
[TBL] [Abstract][Full Text] [Related]
18. Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model.
League-Pascual JC; Lester-McCully CM; Shandilya S; Ronner L; Rodgers L; Cruz R; Peer CJ; Figg WD; Warren KE
J Neurooncol; 2017 May; 132(3):401-407. PubMed ID: 28290002
[TBL] [Abstract][Full Text] [Related]
19. A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates.
Lefevre A; Mottolese R; Dirheimer M; Mottolese C; Duhamel JR; Sirigu A
Sci Rep; 2017 Dec; 7(1):17222. PubMed ID: 29222505
[TBL] [Abstract][Full Text] [Related]
20. A time-dependent peak of oxytocin exists in cerebrospinal fluid but not in plasma of humans.
Amico JA; Tenicela R; Johnston J; Robinson AG
J Clin Endocrinol Metab; 1983 Nov; 57(5):947-51. PubMed ID: 6619269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
